Previous close | 10.71 |
Open | 10.71 |
Bid | 2.55 |
Ask | 9.70 |
Strike | 235.00 |
Expiry date | 2024-06-28 |
Day's range | 10.71 - 10.71 |
Contract range | N/A |
Volume | |
Open interest | N/A |
Is Eli Lilly stock a buy as it looks to enter the obstructive sleep apnea treatment market? Is LLY stock a buy right now?
The FDA grants priority review to Ionis' (IONS) filing seeking approval for olezarsen to treat adults with familial chylomicronemia syndrome. A final decision is expected in December 2024.
Investors need to pay close attention to Biogen (BIIB) stock based on the movements in the options market lately.